News Article | March 2, 2017
Atlantic Health System announces the appointment of otolaryngologist and head and neck surgeon Tom Thomas, MD, MPH as medical director of head and neck reconstructive surgery and transoral robotic surgery for the Leonard B. Kahn Head & Neck Cancer Institute at Morristown Medical Center. Dr. Thomas, who joins head and neck surgeon Erik Cohen, MD, brings innovation and new talent to the Institute’s growing minimally invasive surgery program. A multidisciplinary team of specialists at the Leonard B. Kahn Head & Neck Cancer Institute evaluate and treat the entire spectrum of head and neck cancers, from early stage to the most complex advanced cancers of the throat, voice box, salivary glands, thyroid gland, mouth, lips, nose, and sinuses. Dr. Thomas comes to Atlantic Health System from Dana Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, in Boston where he was the associate director of transoral robotic surgery (TORS). His focus is on minimally invasive surgical techniques such as TORS and Transoral Laser Microsurgery (TLM). “We are excited to have Dr. Thomas join our growing team of highly experienced head and neck specialists,” said Eric Whitman, MD, medical director, Atlantic Health System Cancer Care. “With Dr. Thomas and other nationally-known experts joining our team we are the most comprehensive and highly-skilled head and neck cancer program in New Jersey, and one of the strongest in the nation. “ Dr. Thomas has expertise in treating all head and neck cancers including but not limited to squamous cell carcinoma, basal cell carcinoma, melanoma, Merkel cell carcinoma, various salivary gland carcinomas, thyroid and parathyroid cancers, laryngeal cancers, sinus and skull base cancers. His minimally invasive surgical techniques, combined with a microvascular reconstructive surgical approach, helps to preserve important functions such as speech and swallowing that can be affected by head and neck cancer and its treatments. Dr. Thomas has extensive experience in Human Papilloma Virus (HPV) related head and neck cancer, especially oropharyngeal (tonsil and base of tongue) cancers. He lectures on this topic nationally and internationally. “I am excited to be part of a nationally ranked, magnet healthcare system where the leadership is focused on patient centered care and healthcare innovation,” said Dr. Thomas. “I am looking forward to working with our multidisciplinary head and neck cancer team and growing our head and neck cancer program as the best in the state and in the country.” Head and neck cancer is the sixth most common cancer in the U.S., with more than 60,000 new cases and over 13,000 deaths each year. Though tobacco and alcohol use can raise the risk of developing the disease, exposure to the human papillomavirus (HPV) poses an even greater risk. People who have had an oral HPV infection have a 50 times greater risk of developing head and neck cancer versus the general population. Currently, nearly three quarters of head and neck tumors test positive for HPV. A growing number of these newly diagnosed cases are among men in their forties and fifties.* Dr. Thomas received his medical degree from the Howard University College of Medicine with the highest academic honor of AOA (Alpha Omega Alpha). He completed his surgical internship at The Mayo Clinic in Rochester, MN, and his otolaryngology residency at the Barnes-Jewish Hospital/Washington University School of Medicine in St. Louis, MO. He then had additional fellowship training in head and neck surgical oncology, microvascular surgery and TransOral Robotic Surgery (TORS) at the Hospital of the University of Pennsylvania in Philadelphia. After completing his fellowship, he joined the medical staff at Dana Farber Cancer Institute and was associate surgeon at Harvard Medical School - Brigham and Women's Hospital in Boston. In addition, he has a Master of Public Health degree from John Hopkins School of Public Health in Baltimore. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Thomas’s office is located at Morristown Medical Center, Carol G. Simon Cancer Center, Atlantic Center for Head & Neck Surgery, 100 Madison Avenue, First Floor, Morristown. For more information, call 973-971-7355 or go to atlantichealth.org/headneckcancer. About Atlantic Health System Atlantic Health System, headquartered in Morristown, New Jersey, is one of the largest non-profit healthcare systems in New Jersey. It includes Morristown Medical Center in Morristown, NJ; Overlook Medical Center in Summit, NJ; Newton Medical Center in Newton, NJ; Chilton Medical Center in Pompton Plains, NJ; and Goryeb Children’s Hospital in Morristown, NJ, as well as Atlantic Rehabilitation, and Atlantic Home Care and Hospice. It also includes its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System comprises 1,599 licensed beds, more than 14,000 employees and more than 4,000 physicians. Atlantic Health System has a medical school affiliation with the Sidney Kimmel Medical College at Thomas Jefferson University; a Major Clinical Affiliate of Rutgers Cancer Institute of New Jersey; part of Atlantic Accountable Care Organization, one of the largest ACOs in the nation, and is a member of AllSpire Health Partners.
News Article | February 21, 2017
Two Atlantic Health System Hospitals were recognized in the top one and two percent of hospitals in the nation for clinical excellence by consumer rankings group Healthgrades.® Morristown Medical Center was the only hospital in the state to be recognized as one of ‘America’s 50 Best Hospitals’ for the second consecutive year. Overlook Medical Center was recognized as one of ‘America’s 100 Best Hospitals’ for the second consecutive year. The distinction places Morristown Medical Center in the top one percent and Overlook Medical Center in the top two percent of hospitals in the nation for clinical performance. The two hospitals were the only in New Jersey to be named to these prestigious lists. “Patients can be more secure in their decision to trust Atlantic Health System with their care, given our nationally recognized, consistent commitment to clinical excellence, patient safety, and patient outcomes,” said Trish O’Keefe, PhD, RN, president of Morristown Medical Center. “We make a strong effort to align our medical staff and care teams to deliver exceptional care in a healing environment, and are proud to be recognized for this daily commitment.” “As health care becomes ever more focused on value, the national recognition for Atlantic Health System’s high quality, patient-centered care makes us a clear choice for patients,” said Alan Lieber, president of Overlook Medical Center. “From cutting edge technology to the care teams who guide our patients’ continuum of care inside and outside our walls, our relentless commitment to clinical excellence and patient outcomes is evident at every level.” “The Healthgrades analysis of clinical outcomes shows that there is tremendous variation in care, so it’s important for consumers to research and select a hospital that will provide high-quality care,” said Brad Bowman, chief medical officer, Healthgrades. The recipients of the America’s 50 Best Hospitals Award™ and America’s 100 Best Hospitals Award™ stand out among the rest for overall clinical excellence across a broad spectrum of care. During the 2017 study period (2013-2015), these hospitals showed superior performance in clinical outcomes for patients in the Medicare population across at least 21 of 32 most common inpatient conditions and procedures — as measured by objective performance data (risk-adjusted mortality and in-hospital complications). To learn more about how Healthgrades determines America’s 50 Best Hospitals Award™ recipients, please visit http://www.healthgrades.com/quality. *Statistics are based on Healthgrades analysis of MedPAR data for years 2013 through 2015 and represent 3-year estimates for Medicare patients only. For more information on methodology, visit http://www.healthgrades.com/quality. About Atlantic Health System Atlantic Health System, headquartered in Morristown, New Jersey, is a leading non-profit health care delivery system in New Jersey. Our network includes Morristown Medical Center in Morristown, NJ; Overlook Medical Center in Summit, NJ; Newton Medical Center in Newton, NJ; Chilton Medical Center in Pompton Plains, NJ; Hackettstown Medical Center in Hackettstown, NJ; and Goryeb Children’s Hospital in Morristown, NJ, as well as Atlantic Rehabilitation, and Atlantic Home Care and Hospice. It also includes its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System comprises 1,747 licensed beds, more than 14,000 employees and more than 4,000 physicians. Atlantic Health System has a medical school affiliation with the Sidney Kimmel Medical College at Thomas Jefferson University; is part of Atlantic Accountable Care Organization, one of the largest ACOs in the nation, and is a member of AllSpire Health Partners.
News Article | February 16, 2017
Atlantic Health System’s Annual Heart Failure Awareness Week Symposium will highlight the latest research, programs, and clinical advances in heart failure. The 6th annual, day-long scientific symposium, to be held on February 17, during National Heart Failure Awareness Week, will feature ten Atlantic Health System clinicians presenting on topics including: Claire G. Boccia Liang, MD, FACC, Director of the Women’s Heart Program at Atlantic Health System, will present a keynote on congenital heart disease. “As a nationally recognized leader in cardiology, Atlantic Health System is committed to ensuring that its medical teams have access to the latest research, technology, and care delivery models so patients with heart failure receive optimal treatment that will both prolong and improve the quality of life,” said Linda Gillam, MD, MPH, chair, Department of Cardiovascular Medicine, Atlantic Health System. “The Annual Heart Failure Awareness Week Symposium also affords attendees a chance for discussion and healthy debate among multi-disciplinary care teams.” Atlantic Health System, headquartered in Morristown, New Jersey, is a leading non-profit health care delivery system in New Jersey. Our network includes Morristown Medical Center in Morristown, NJ; Overlook Medical Center in Summit, NJ; Newton Medical Center in Newton, NJ; Chilton Medical Center in Pompton Plains, NJ; Hackettstown Medical Center in Hackettstown, NJ; and Goryeb Children’s Hospital in Morristown, NJ, as well as Atlantic Rehabilitation, and Atlantic Home Care and Hospice. It also includes its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System comprises 1,747 licensed beds, more than 14,000 employees and more than 4,000 physicians. Atlantic Health System has a medical school affiliation with the Sidney Kimmel Medical College at Thomas Jefferson University; is part of Atlantic Accountable Care Organization, one of the largest ACOs in the nation, and is a member of AllSpire Health Partners.
News Article | December 19, 2016
LOUISVILLE, Ky. & MORRISTOWN, N.J.--(BUSINESS WIRE)--Kindred Healthcare, Inc. (“Kindred”) (NYSE:KND) and Atlantic Health System today announced the signing of a definitive agreement to create a joint venture to construct and operate a 38-bed inpatient rehabilitation hospital in northern New Jersey. The new facility will offer all private rooms, supporting both enhanced clinical efficiency and elevated patient experience with targeted clinical programs including neurological, spine, trauma and complex conditions. The growth in trauma cases and the increased level of acuity of patients served by Atlantic Health System has resulted in more patients requiring inpatient rehabilitation services in order to improve their functional status prior to returning home. The combination of Kindred’s expertise and a modern, state-of-the-art facility will allow Atlantic Health System to maximize its ability to serve a growing population of patients with critical needs. Subject to several regulatory and other approvals, Kindred and Atlantic Health System expect the rehabilitation facility to open by the fourth quarter of 2018. The new hospital will enhance Kindred’s existing services in New Jersey, which include three long-term acute care (“LTAC”) hospitals and hospice services. “We are confident that our partnership with Atlantic Health System, New Jersey’s premier health system, will address the growing need for inpatient rehabilitation services in the New Jersey and New York area as we build and operate a new facility together,” said Jason Zachariah, President of Kindred Rehabilitation Services, a division of Kindred. “This quality-focused collaboration with a leading healthcare system will deliver the kind of excellent care that improves patients’ lives and enables our inpatient rehabilitation business to continuously outperform peers in key clinical measures.” “By joining together with Kindred, which has a proven record of industry-leading clinical outcomes, we are expanding a service that our community needs and deserves,” said Brian Gragnolati, President and Chief Executive Officer, Atlantic Health System. “A dedicated inpatient rehabilitation hospital designed to promote healing will bring a higher level of care to improve the lives of our patients and their families.” Kindred Healthcare, Inc., a top-90 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville, Kentucky with annual revenues of approximately $7.2 billion(1). As of October 1, 2016, Kindred through its subsidiaries had approximately 102,200 employees providing healthcare services in 2,702 locations in 46 states, including 82 LTAC hospitals, 19 inpatient rehabilitation hospitals, 91 nursing centers, 19 sub-acute units, 647 Kindred at Home home health, hospice and non-medical home care sites of service, 104 inpatient rehabilitation units (hospital-based) and contract rehabilitation service businesses which served 1,740 non-affiliated sites of service. Ranked as one of Fortune magazine’s Most Admired Healthcare Companies for seven years, Kindred’s mission is to promote healing, provide hope, preserve dignity and produce value for each patient, resident, family member, customer, employee and shareholder we serve. For more information, go to www.kindredhealthcare.com. You can also follow us on Twitter and Facebook. Atlantic Health System, headquartered in Morristown, New Jersey, is a leading non-profit health care delivery system in New Jersey. Our network includes Morristown Medical Center in Morristown, NJ; Overlook Medical Center in Summit, NJ; Newton Medical Center in Newton, NJ; Chilton Medical Center in Pompton Plains, NJ; Hackettstown Medical Center in Hackettstown, NJ; and Goryeb Children’s Hospital in Morristown, NJ, as well as Atlantic Rehabilitation, and Atlantic Home Care and Hospice. It also includes its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System comprises 1,747 licensed beds, more than 14,000 employees and more than 4,000 physicians. Atlantic Health System has a medical school affiliation with the Sidney Kimmel Medical College at Thomas Jefferson University; is part of Atlantic Accountable Care Organization, one of the largest ACOs in the nation, and is a member of AllSpire Health Partners.
News Article | February 15, 2017
Matthew Regulski, D.P.M., the Director of the Wound Care Institute of Ocean County, recently conducted a lecture on biofilm and DNA testing at the Rahway Medical Center and Overlook Medical Center’s Wound Care Center in Union, NJ. The lecture focused on DNA molecular testing on biofilm, which inhibits wound healing in the diabetic community, as well as all chronic wounds. “To understand wound healing, you must understand the role of biofilm in the human body,” said Regulski. “Biofilm is a community of several different bacteria that come together through a process called quorum sensing. This process enables the biofilm to communicate with each other and spread their virulence through the production of extracellular polymeric substance (EPS).” Wounds fail to heal when biofilm is present, so it must first be identified which type of bacteria is in the biofilm in order to destroy it and facilitate wound healing, Regulski notes. “By reducing the biofilm, we reduce the inflammation that has a deleterious effect upon many tissues and cells,” he added. To do this, Regulski utilizes a process called DNA molecular testing. “The DNA sequencing can identify over 25,000 different bacteria and fungi that can inhabit a chronic wound,” he said. “There are over 10 trillion bacteria on our skin. There will always be some kind of bacterial contamination in any open wound. Through DNA testing, we can make a topical antibiotic cream that is thousands of times stronger than anything you can ever take by mouth. It has to be that strong in order to penetrate through the biofilm, which oral antibiotics are not strong enough to do, and, in some cases, intravenous antibiotics are not strong enough either. This is because the concentration cannot be raised high enough without harming the patient’s kidneys and organs.” “DNA contains the instructions each cell in an organism on Earth needs to live,” according to a NASA.gov press release (https://www.nasa.gov/mission_pages/station/research/news/dna_sequencing). “The Biomolecule Sequencer investigation moved us closer to this ability to sequence DNA in space by demonstrating that DNA sequencing is possible in an orbiting spacecraft. With a way to sequence DNA in space, astronauts could diagnose an illness, or identify microbes growing in the International Space Station and determining whether or not they represent a health threat.” This space-based DNA sequencer could help protect astronaut health during missions, and future explorers could also use the technology to identify DNA-based life forms beyond Earth, according to Regulski. Today, DNA testing is very helpful in the treatment of chronic infections. The National Institutes of Health (NIH) says that 60-70 percent of all infections are due to biofilm. Any chronic infection is due to biofilm, including chronic ear infections, chronic prostate infections, sinusitis, recurrent bladder infections, cystic fibrosis, bronchitis, as well as orthopedic implant infections (knee and hip replacements), according to Regulski. “We used this technology clinically in orthopedics, otolaryngology, urology and chronic wound care therapy in the diabetic community and beyond to more accurately identify and more specifically target antibiotic therapy,” Regulski added. “It truly is revolutionary and will significantly aid in the treatment and resolution of all chronic infectious processes.” For more information about the Wound Care Institute of Ocean County or its several locations or services, visit http://www.woundcareinstituteofoceancounty.com or call 732-736-5509. About the Wound Care Institute of Ocean County The Wound Care Institute of Ocean County is the leader in wound care management, and is dedicated to the diagnosis and successful treatment of chronic and debilitating wounds. The Wound Care Institute follows the highest levels of evidence-based medicine and offers various treatment algorithms using the most advanced cellular therapies, as well as vascular services and surgical reconstruction. The Wound Care Institute of Ocean County is also involved in multiple clinical trials that have tremendous impact on the way wound healing is performed. To learn more, visit woundcareinstituteofoceancounty.com.
Halperin J.J.,Overlook Medical Center
Infection and Drug Resistance | Year: 2015
Lyme disease, infection with the tick-borne spirochete Borrelia burgdorferi, causes both specific and nonspecific symptoms. In untreated chronic infection, specific manifestations such as a relapsing large-joint oligoarthritis can persist for years, yet subside with appropriate antimicrobial therapy. Nervous system involvement occurs in 10%–15% of untreated patients and typically involves lymphocytic meningitis, cranial neuritis, and/or mononeuritis multiplex; in some rare cases, patients have parenchymal inflammation in the brain or spinal cord. Nervous system infection is similarly highly responsive to antimicrobial therapy, including oral doxycycline. Nonspecific symptoms such as fatigue, perceived cognitive slowing, headache, and others occur in patients with Lyme disease and are indistinguishable from comparable symptoms occurring in innumerable other inflammatory states. There is no evidence that these nonspecific symptoms reflect nervous system infection or damage, or that they are in any way specific to or diagnostic of this or other tick-borne infections. When these symptoms occur in patients with Lyme disease, they typically also subside after antimicrobial treatment, although this may take time. Chronic fatigue states have been reported to occur following any number of infections, including Lyme disease. The mechanism underlying this association is unclear, although there is no evidence in any of these infections that these chronic posttreatment symptoms are attributable to ongoing infection with B. burgdorferi or any other identified organism. Available appropriately controlled studies indicate that additional or prolonged courses of antimicrobial therapy do not benefit patients with a chronic fatigue-like state after appropriately treated Lyme disease. © 2015 by Duke University Press.
Halperin J.J.,Overlook Medical Center |
Halperin J.J.,Mount Sinai School of Medicine
Infectious Disease Clinics of North America | Year: 2015
Lymphocytic meningitis, cranial neuritis or radiculoneuritis occur in up to 15% of patients with untreated Borrelia burgdorferi infection. Presentations of multifocal PNS involvement can range from painful monoradiculitis to confluent mononeuropathy multiplex. Serologic testing is highly accurate after 4 to 6 weeks of infection. In CNS infection, production of anti-. B burgdorferi antibody is often demonstrable in CSF. Oral antimicrobials are microbiologically curative in virtually all patients, including acute European neuroborreliosis. Severe cases may require parenteral treatment. The fatigue and cognitive symptoms seen in some patients with extra-neurological disease are neither evidence of CNS infection nor specific to Lyme disease. © 2015 Elsevier Inc.
Halperin J.J.,Overlook Medical Center
CONTINUUM Lifelong Learning in Neurology | Year: 2012
Purpose of Review: This article will enable the reader to diagnose and treat nervous system Lyme disease appropriately.Recent Findings: Appropriately applied serologic testing has high positive and negative predictive values in nervous system Lyme disease. Oral antibiotics can be curative in most cases.Summary: Infection with the tick-transmitted spirochete Borrelia burgdorferi causes Lyme disease, a disorder that involves the nervous system in about 15% of patients. Common manifestations include lymphocytic meningitis, cranial neuritis (particularly cranial nerve VII), painful radiculitis, other forms of mononeuropathy multiplex, and rarely CNS parenchymal involvement. Diagnosis is supported primarily by demonstration of anti-B. burgdorferi antibodies in serum. CSF examination can be informative in problematic cases with parenchymal CNS infection or to identify meningitis. However, oral antibiotics are probably effective in patients with meningitis and other forms of involvement, with the likely exception of parenchymal CNS infection. © 2012, American Academy of Neurology.
Halperin J.J.,Overlook Medical Center
Handbook of Clinical Neurology | Year: 2014
Lyme disease, the multisystem infectious disease caused by the tick-borne spirochete Borrelia burgdorferi involves the nervous system in 10-15% of affected individuals. Manifestations include lymphocytic meningitis, cranial neuritis, radiculoneuritis, and mononeuropathy multiplex. Encephalopathy, identical to that seen in many systemic inflammatory diseases, can occur during active systemic infection. It is not specific to Lyme disease and only rarely is evidence of nervous system infection. Diagnosis of systemic disease is based on demonstration of specific antibodies in peripheral blood by means of two-tier testing with an ELISA and Western blot. Central nervous system infection often results in specific antibody production in the CSF, demonstrable by comparing spinal fluid to blood serologies. Treatment is straightforward and curative in most instances. Many patients can be treated effectively with oral antibiotics such as doxycycline; in severe CNS infection parenteral treatment with ceftriaxone or other similar agents is highly effective. Treatment should usually be for 2 to at most 4 weeks. Longer treatment adds no therapeutic benefit but does add substantial risk. © 2014 Elsevier B.V.
News Article | November 10, 2016
SUMMIT, N.J., Nov. 10, 2016 /PRNewswire/ -- Atlantic Health System and Overlook Medical Center announced today the launch of "Take Me There - Overlook," an innovative mobile app that helps patients and their families to easily navigate throughout the hospital. Photo - http://photos.p...